Revolutionary Parkinson’s Treatment Breakthrough at King’s College Hospital Dubai
In a groundbreaking development, King’s College Hospital London in Dubai has brought new hope to Parkinson’s patients by successfully administering subcutaneous levodopa (fos-levodopa) pump therapy to the youngest Parkinson’s patient in the UAE and the MENA region.
Personalized Care for Parkinson’s Patients
Diagnosed with Parkinson’s disease at the young age of 30, the patient had been living with the disorder for 14 years, requiring full-time assistance from three caregivers. This innovative treatment represents a significant leap forward in Parkinson’s care, offering potential improvements to the patient’s quality of life.
The introduction of Foslevodopa pump therapy in the Middle East by King’s College Hospital Dubai has revolutionized the treatment of Parkinson’s disease. This therapy involves the continuous delivery of levodopa through the patient’s skin via a pump, similar to an insulin pump for diabetes. Dosage is tailored to each patient’s specific needs, ensuring optimal care under the supervision of specialists like Dr. Vinod Metta and Prof. Ray Chaudhuri. With this innovative pump, patients can regain independence and perform daily tasks with ease, including fasting during Ramadan.
“Personalized care and individualized dosing are crucial in Parkinson’s treatment,” stated Dr. Vinod Metta, Consultant Interventional Neurologist and Parkinson’s Specialist at King’s College Hospital London in Dubai. “With the Foslevodopa pump, patients can take control of their disease, regain independence, and enhance their quality of life.”
Parkinson’s Center of Excellence
The procedure was carried out at the Parkinson’s Center of Excellence in King’s College Hospital Dubai, a hub of excellence for movement disorders. This center offers top-notch diagnostic and treatment innovations, along with comprehensive support for Parkinson’s patients and their families, emphasizing patient-centered care.
Prof. Ray Chaudhuri, a renowned expert in neurology and movement disorders at King’s College Hospital London, hailed the introduction of Foslevodopa as a monumental advancement in personalized therapy, ensuring patients receive the best possible care.
King’s Parkinson’s Centre of Excellence: Leading the Future of Parkinson’s Care
Under the guidance of UK-trained Parkinson’s specialists like Dr. Vinod Metta and Prof. Ray Chaudhuri, King’s Parkinson’s Centre of Excellence in Dubai offers personalized treatment plans supported by a multidisciplinary team of experts. The center, led by Dr. Metta, has treated over 1,000 Parkinson’s patients across the Gulf Cooperation Council countries.
For more information about the foslevodopa/foscarbidopa pump treatment, please contact King’s Parkinson’s Centre of Excellence:
-
Ms. Therese Masagnay: Therese.Masagnay@kch.ae
-
Ms. Clarissa Sanglian: Clarissa.Sanglian@kch.ae
-
Research Studies & Clinical Trials Coordinator: Afsal.Nalarakettil@kch.ae
This breakthrough treatment offers new hope for Parkinson’s patients in the UAE and beyond.
